Search results for Galcanezumab
Galcanezumab, Abbexa, abx831382
Galcanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CALCA/CGRP1/CALCB/CGRP2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. LY2951742/galcanezumab is a fully humanized monoclonal antibody against human calcitonin gene-related peptide (CGRP) that is developed by ELi Lilly and Company. This therapy is given as a single subcutaneous injection twice a month and ongoing clinical trials for the agent are for episodic and chronic migraine as well as cluster headaches.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Galcanezumab Biosimilar - Research Grade, ichor.bio, ICH5046
Detects human CGRP. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Galcanezumab.
Host
Reactivity
Human
Applications
Conjugation
Research Grade Galcanezumab (HY028016), abinScience, HY028016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.